Status:
WITHDRAWN
Intraabdominal Chloroprocaine During Cesarean Delivery for Pain Control
Lead Sponsor:
Johns Hopkins University
Conditions:
Cesarean Section Complications
Pain
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
Objective The objective of this study is to test the hypothesis that instillation of intra-abdominal chloroprocaine during cesarean deliveries is associated with decreased postoperative pain and nause...
Detailed Description
Postoperative pain relief is an important consideration during and after cesarean section. Although many different methods have been described for proper pain relief, it remains not sufficient and sat...
Eligibility Criteria
Inclusion
- Pregnant women with a singleton or multiple pregnancies, vertex or breech presentation presenting to our labor and delivery unit for an elective cesarean section will be eligible for participation.
Exclusion
- Women will be excluded if any of the following criteria are encountered: Allergy against local anesthetics - ascertained or presumptive hypersensitivity to the ester type and major anesthetics; chronic pelvic pain and refusal to participate in the study.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03260972
Start Date
June 1 2021
End Date
June 1 2023
Last Update
September 29 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.